These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 30168698)

  • 1. [Molecular-targeted Therapies in Gastrointestinal Cancer].
    Kondo S
    Nihon Naika Gakkai Zasshi; 2016 Jun; 105(6):1051-60. PubMed ID: 30168698
    [No Abstract]   [Full Text] [Related]  

  • 2. Targeted therapies in upper gastrointestinal malignancies.
    Azzariti A; Silvestris N
    Curr Med Chem; 2014; 21(8):947. PubMed ID: 23992326
    [No Abstract]   [Full Text] [Related]  

  • 3. [Novel molecular-targeted agents for GIST(Regorafenib etc.)].
    Naito Y; Doi T
    Gan To Kagaku Ryoho; 2013 Jan; 40(1):15-8. PubMed ID: 23306914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful gastrointestinal cancer drug development.
    Hecht JR
    Semin Oncol; 2006 Dec; 33(6 Suppl 11):S24-7. PubMed ID: 17178281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel therapeutic agents for the treatment of gastroenteropancreatic neuroendocrine tumors.
    Pavel ME; Wiedenmann B
    Horm Metab Res; 2011 Nov; 43(12):844-53. PubMed ID: 22105475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical evaluation strategy in specific disease types - clinical study of gastrointestinal cancer chemotherapy in one institute of Japan.
    Saito T
    Recent Results Cancer Res; 1980; 70():187-202. PubMed ID: 6986642
    [No Abstract]   [Full Text] [Related]  

  • 7. The role of nanotechnology in gastrointestinal cancer.
    Vyas D; Castro P; Saadeh Y; Vyas A
    J Biomed Nanotechnol; 2014 Nov; 10(11):3204-18. PubMed ID: 26000381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of targeted therapy for gastrointestinal tumors.
    Rolfo C; Bronte G; Sortino G; Papadimitriou K; Passiglia F; Fiorentino E; Marogy G; Russo A; Peeters M
    Expert Rev Gastroenterol Hepatol; 2014 Nov; 8(8):875-85. PubMed ID: 24957206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of pharmacokinetic studies for patients with gastrointestinal stromal tumors.
    De Giorgi U
    Future Oncol; 2013 Nov; 9(11):1675-7. PubMed ID: 23862700
    [No Abstract]   [Full Text] [Related]  

  • 10. Unravelling the pharmacologic opportunities and future directions for targeted therapies in gastro-intestinal cancers Part 1: GI carcinomas.
    Neuzillet C; Rousseau B; Kocher H; Bourget P; Tournigand C
    Pharmacol Ther; 2017 Jun; 174():145-172. PubMed ID: 28223233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beyond standard therapy: drugs under investigation for the treatment of gastrointestinal stromal tumor.
    Alturkmani HJ; Pessetto ZY; Godwin AK
    Expert Opin Investig Drugs; 2015; 24(8):1045-58. PubMed ID: 26098203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [New developments in chemotherapy of gastrointestinal carcinomas].
    Hartung G
    Onkologie; 2001 Sep; 24 Suppl 5():10-5. PubMed ID: 11600807
    [No Abstract]   [Full Text] [Related]  

  • 13. Unravelling the pharmacologic opportunities and future directions for targeted therapies in gastro-intestinal cancers part 2: Neuroendocrine tumours, hepatocellular carcinoma, and gastro-intestinal stromal tumours.
    Neuzillet C; de Mestier L; Rousseau B; Mir O; Hebbar M; Kocher HM; Ruszniewski P; Tournigand C
    Pharmacol Ther; 2018 Jan; 181():49-75. PubMed ID: 28723416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy in the management of malignant gastrointestinal disease.
    Canfield V; Mortimer JE
    Gastroenterol Clin North Am; 1992 Sep; 21(3):695-714. PubMed ID: 1516963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemoradiotherapy for gastrointestinal cancers.
    Rich TA; Crane C; Lawson JD; Landry J
    Curr Oncol Rep; 2005 May; 7(3):196-202. PubMed ID: 15847710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Indications and results of cytostatic therapy in gastrointestinal tumors].
    Brunner KW
    Schweiz Med Wochenschr; 1973 Feb; 103(5):171-8. PubMed ID: 4119603
    [No Abstract]   [Full Text] [Related]  

  • 17. Chronotherapy with 5-fluorouracil and other drugs in gastrointestinal malignancies. Chronotherapy Group of the European Organization for Research and Treatment of Cancer.
    Misset JL; Lévi F
    Semin Oncol; 2000 Oct; 27(5 Suppl 10):78-82. PubMed ID: 11049036
    [No Abstract]   [Full Text] [Related]  

  • 18. Imatinib mesylate--a new oral targeted therapy.
    Savage DG; Antman KH
    N Engl J Med; 2002 Feb; 346(9):683-93. PubMed ID: 11870247
    [No Abstract]   [Full Text] [Related]  

  • 19. Targeting dynamics of subclones of GI, liver and pancreatic cancers.
    Ziogas DE; Glantzounis G; Liakakos T; Roukos DH
    Expert Rev Gastroenterol Hepatol; 2016 Jul; 10(7):773-6. PubMed ID: 27143511
    [No Abstract]   [Full Text] [Related]  

  • 20. Community practice and cancer clinical trials: IV. Relationship between early toxicity and treatment outcomes in GI cancer patients.
    Steinberg SM; Hall TC
    Hawaii Med J; 1986 Aug; 45(8):263-5. PubMed ID: 3531091
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.